Vyant Bio Inc. sell Global_Player
Start price
30.03.22
/
50%
€8.50
Target price
30.03.23
-
Performance (%)
-24.12%
End price
31.03.22
€6.45
Summary
This prediction ended on 31.03.22 with a price of €6.45. The price of Vyant Bio Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -24.12%. Global_Player has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to Global_Player what are the pros and cons of Vyant Bio Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Global_Player for this prediction
In the thread Cancer Genetics Inc. diskutieren
Sell Vyant Bio Inc.